165 related articles for article (PubMed ID: 38307819)
21. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.
Nakai H; Yant SR; Storm TA; Fuess S; Meuse L; Kay MA
J Virol; 2001 Aug; 75(15):6969-76. PubMed ID: 11435577
[TBL] [Abstract][Full Text] [Related]
22. Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat.
Reimsnider S; Manfredsson FP; Muzyczka N; Mandel RJ
Mol Ther; 2007 Aug; 15(8):1504-11. PubMed ID: 17565350
[TBL] [Abstract][Full Text] [Related]
23. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.
Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N
Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells.
Teschendorf C; Emons B; Muzyczka N; Graeven U; Schmiegel W
Anticancer Res; 2010 Jun; 30(6):1931-5. PubMed ID: 20651336
[TBL] [Abstract][Full Text] [Related]
25. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
26. Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery.
Towne C; Pertin M; Beggah AT; Aebischer P; Decosterd I
Mol Pain; 2009 Sep; 5():52. PubMed ID: 19737386
[TBL] [Abstract][Full Text] [Related]
27. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction.
Nakai H; Thomas CE; Storm TA; Fuess S; Powell S; Wright JF; Kay MA
J Virol; 2002 Nov; 76(22):11343-9. PubMed ID: 12388694
[TBL] [Abstract][Full Text] [Related]
28. Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trials.
Minella AL; Mowat FM; Willett KL; Sledge D; Bartoe JT; Bennett J; Petersen-Jones SM
Gene Ther; 2014 Oct; 21(10):913-20. PubMed ID: 25056608
[TBL] [Abstract][Full Text] [Related]
29. Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes.
Ulrich-Vinther M; Maloney MD; Goater JJ; Søballe K; Goldring MB; O'Keefe RJ; Schwarz EM
Arthritis Rheum; 2002 Aug; 46(8):2095-104. PubMed ID: 12209514
[TBL] [Abstract][Full Text] [Related]
30. Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy.
Liu J; Saghizadeh M; Tuli SS; Kramerov AA; Lewin AS; Bloom DC; Hauswirth WW; Castro MG; Schultz GS; Ljubimov AV
Mol Vis; 2008; 14():2087-96. PubMed ID: 19023450
[TBL] [Abstract][Full Text] [Related]
31. Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis.
Uhrig S; Coutelle O; Wiehe T; Perabo L; Hallek M; Büning H
Gene Ther; 2012 Feb; 19(2):210-8. PubMed ID: 21654820
[TBL] [Abstract][Full Text] [Related]
32. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction.
Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O
Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770
[TBL] [Abstract][Full Text] [Related]
33. Effect of polyethylenimine on recombinant adeno-associated virus mediated insulin gene therapy.
Hsu PY; Yang YW
J Gene Med; 2005 Oct; 7(10):1311-21. PubMed ID: 15906397
[TBL] [Abstract][Full Text] [Related]
34. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.
Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Wenz F; Fruehauf S; Zeller WJ; Veldwijk MR
Exp Hematol; 2008 Aug; 36(8):957-64. PubMed ID: 18495326
[TBL] [Abstract][Full Text] [Related]
35. Incorporation of calcium phosphate enhances recombinant adeno-associated virus-mediated gene therapy in diabetic mice.
Yang YW; Chao CK
J Gene Med; 2003 May; 5(5):417-24. PubMed ID: 12731090
[TBL] [Abstract][Full Text] [Related]
36. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain.
Wang C; Wang CM; Clark KR; Sferra TJ
Gene Ther; 2003 Aug; 10(17):1528-34. PubMed ID: 12900769
[TBL] [Abstract][Full Text] [Related]
37. Glucose-modulated transgene expression via recombinant adeno-associated virus.
Yang YW; Hsieh YC; Chao CK
Pharm Res; 2002 Jul; 19(7):968-75. PubMed ID: 12180549
[TBL] [Abstract][Full Text] [Related]
38. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
[TBL] [Abstract][Full Text] [Related]
39. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
40. Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle.
Ohshima S; Shin JH; Yuasa K; Nishiyama A; Kira J; Okada T; Takeda S
Mol Ther; 2009 Jan; 17(1):73-80. PubMed ID: 18941441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
